Melissa A. Culhane

2.4k total citations
21 papers, 1.9k citations indexed

About

Melissa A. Culhane is a scholar working on Psychiatry and Mental health, Molecular Biology and Physiology. According to data from OpenAlex, Melissa A. Culhane has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Melissa A. Culhane's work include Smoking Behavior and Cessation (6 papers), Schizophrenia research and treatment (6 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). Melissa A. Culhane is often cited by papers focused on Smoking Behavior and Cessation (6 papers), Schizophrenia research and treatment (6 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). Melissa A. Culhane collaborates with scholars based in United States, Netherlands and Rwanda. Melissa A. Culhane's co-authors include A. Eden Evins, Donald Goff, Oliver Freudenreich, Diego A. Pizzagalli, David C. Henderson, Corinne Cather, Thilo Deckersbach, Ruth S. Barr, Gladys N. Pachas and Maurizio Fava and has published in prestigious journals such as Biological Psychiatry, Journal of the American Academy of Child & Adolescent Psychiatry and Cellular and Molecular Life Sciences.

In The Last Decade

Melissa A. Culhane

21 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa A. Culhane United States	19	603	527	522	368	360	21	1.9k
Jennifer C. Vessicchio United States	17	678 1.1×	554 1.1×	323 0.6×	253 0.7×	385 1.1×	20	1.6k
Kristi A. Sacco United States	19	557 0.9×	620 1.2×	353 0.7×	290 0.8×	213 0.6×	20	1.4k
Marc Mooney United States	30	726 1.2×	413 0.8×	299 0.6×	508 1.4×	300 0.8×	50	1.8k
Steven D. LaRowe United States	27	410 0.7×	417 0.8×	233 0.4×	872 2.4×	333 0.9×	46	2.2k
Sean P. Barrett Canada	21	536 0.9×	372 0.7×	291 0.6×	470 1.3×	610 1.7×	79	2.3k
Himanshu P. Upadhyaya United States	33	667 1.1×	344 0.7×	1.3k 2.4×	460 1.3×	678 1.9×	77	3.0k
Edward G. Singleton United States	27	854 1.4×	544 1.0×	296 0.6×	680 1.8×	455 1.3×	46	2.8k
Elise E. DeVito United States	32	469 0.8×	413 0.8×	425 0.8×	895 2.4×	461 1.3×	84	3.0k
Dale S. Cannon United States	27	507 0.8×	489 0.9×	155 0.3×	473 1.3×	311 0.9×	63	2.1k
Catherine P. Domier United States	17	254 0.4×	297 0.6×	223 0.4×	607 1.6×	190 0.5×	19	1.7k

Countries citing papers authored by Melissa A. Culhane

Since Specialization

Citations

This map shows the geographic impact of Melissa A. Culhane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa A. Culhane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa A. Culhane more than expected).

Fields of papers citing papers by Melissa A. Culhane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa A. Culhane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa A. Culhane. The network helps show where Melissa A. Culhane may publish in the future.

Co-authorship network of co-authors of Melissa A. Culhane

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa A. Culhane. A scholar is included among the top collaborators of Melissa A. Culhane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa A. Culhane. Melissa A. Culhane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janes, Amy C., Diego A. Pizzagalli, Blaise deB. Frederick, et al.. (2010). Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence. Biological Psychiatry. 67(8). 722–729. 335 indexed citations

Cohen, Mardge H., Qiuhu Shi, Donald R. Hoover, et al.. (2009). Prevalence and Predictors of Posttraumatic Stress Disorder and Depression in HIV-Infected and At-Risk Rwandan Women. Journal of Women s Health. 18(11). 1783–1791. 54 indexed citations

Dyer, Michael A., Oliver Freudenreich, Melissa A. Culhane, et al.. (2008). High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophrenia Research. 102(1-3). 88–95. 55 indexed citations

Evins, A. Eden, Melissa A. Culhane, Jonathan E. Alpert, et al.. (2008). A Controlled Trial of Bupropion Added to Nicotine Patch and Behavioral Therapy for Smoking Cessation in Adults With Unipolar Depressive Disorders. Journal of Clinical Psychopharmacology. 28(6). 660–666. 54 indexed citations

Angarita, Gustavo A., Gladys N. Pachas, Kai‐Lin Huang, et al.. (2008). A Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Risperidone in Cocaine-Dependent Men. The Journal of Clinical Psychiatry. 69(3). 480–486. 28 indexed citations

Culhane, Melissa A., David Schoenfeld, Ruth S. Barr, et al.. (2008). Predictors of Early Abstinence in Smokers With Schizophrenia. The Journal of Clinical Psychiatry. 69(11). 1743–1750. 38 indexed citations

Goff, Donald, Corinne Cather, Oliver Freudenreich, et al.. (2008). A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology. 202(1-3). 411–417. 55 indexed citations

Barr, Ruth S., Melissa A. Culhane, Lindsay E. Jubelt, et al.. (2007). The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls. Neuropsychopharmacology. 33(3). 480–490. 188 indexed citations

Freudenreich, Oliver, David C. Henderson, Jared P. Walsh, Melissa A. Culhane, & Donald Goff. (2007). Risperidone augmentation for schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled trial. Schizophrenia Research. 92(1-3). 90–94. 77 indexed citations

10.

Pizzagalli, Diego A., A. Eden Evins, Michael J. Frank, et al.. (2007). Single dose of a dopamine agonist impairs reinforcement learning in humans: Behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology. 196(2). 221–232. 170 indexed citations

11.

Barr, Ruth S., Diego A. Pizzagalli, Melissa A. Culhane, Donald Goff, & A. Eden Evins. (2007). A Single Dose of Nicotine Enhances Reward Responsiveness in Nonsmokers: Implications for Development of Dependence. Biological Psychiatry. 63(11). 1061–1065. 108 indexed citations

12.

Evins, A. Eden, Corinne Cather, Melissa A. Culhane, et al.. (2007). A 12-Week Double-Blind, Placebo-Controlled Study of Bupropion SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation or Reduction in Schizophrenia. Journal of Clinical Psychopharmacology. 27(4). 380–386. 140 indexed citations

13.

Evins, A. Eden, Christina M. Demopulos, Andrew A. Nierenberg, et al.. (2006). A double‐blind, placebo‐controlled trial of adjunctive donepezil in treatment‐resistant mania. Bipolar Disorders. 8(1). 75–80. 30 indexed citations

14.

Evins, A. Eden, Christina M. Demopulos, Iftah Yovel, et al.. (2006). Inositol augmentation of lithium or valproate for bipolar depression. Bipolar Disorders. 8(2). 168–174. 54 indexed citations

15.

Henderson, David C., Christina P. C. Borba, Tara B. Daley, et al.. (2006). Dietary Intake Profile of Patients with Schizophrenia. Annals of Clinical Psychiatry. 18(2). 99–105. 103 indexed citations

16.

Henderson, David C., Richard F. Mollica, Svang Tor, et al.. (2005). Building Primary Care Practitioners’ Attitudes and Confidence in Mental Health Skills in a Post-Conflict Society. The Journal of Nervous and Mental Disease. 193(8). 551–559. 15 indexed citations

17.

Evins, A. Eden, Corinne Cather, Thilo Deckersbach, et al.. (2005). A Double-blind Placebo-Controlled Trial of Bupropion Sustained-Release for Smoking Cessation in Schizophrenia. Journal of Clinical Psychopharmacology. 25(3). 218–225. 157 indexed citations

18.

Evins, A. Eden, Thilo Deckersbach, Corinne Cather, et al.. (2005). Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia. The Journal of Clinical Psychiatry. 66(9). 1184–1190. 46 indexed citations

19.

Rettew, David C., Mary C. Zanarini, Shirley Yen, et al.. (2003). Childhood Antecedents of Avoidant Personality Disorder: A Retrospective Study. Journal of the American Academy of Child & Adolescent Psychiatry. 42(9). 1122–1130. 36 indexed citations

20.

Eisen, Susan V., Marsha Wilcox, H. Stephen Leff, Elizabeth Schaefer, & Melissa A. Culhane. (1999). Assessing behavioral health outcomes in outpatient programs: Reliability and validity of the BASIS-32. Cellular and Molecular Life Sciences. 26(1). 5–17. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact